Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis
Grace C. Pyon(Mayo Clinic in Arizona), Alfred D. Doyle(Mayo Clinic in Arizona), Mia Y. Masuda(Mayo Clinic in Arizona), Hirohito Kita(Mayo Clinic), Hiroshi Nakagawa(The Wistar Institute), Rish K. Pai(Cincinnati Children's Hospital Medical Center), Jessica B. Gibson(Mayo Clinic in Arizona), Matthew A. Rank(Mayo Clinic in Arizona), Arina Putikova(Mayo Clinic in Arizona), Shipra Garg(Phoenix Children's Hospital), Benjamin L. Wright(Phoenix Children's Hospital), Huijun Luo(Johnson University), Piper Heiligenstein(WinnMed), James Bonellos(WinnMed), Adelyn Dao(WinnMed), Danna R. Ortiz(WinnMed), William E. LeSuer(WinnMed)
Cited by 7
Related Papers
Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis
|Journal of Allergy and Clinical Immunology|2020|676
IL-33–Responsive Lineage−CD25+CD44hi Lymphoid Cells Mediate Innate Type 2 Immunity and Allergic Inflammation in the Lungs
|The Journal of Immunology|2011|537
Drug allergy: A 2022 practice parameter update
|Journal of Allergy and Clinical Immunology|2022|504
Rhinitis 2020: A practice parameter update
|Journal of Allergy and Clinical Immunology|2020|399
Enhanced innate type 2 immune response in peripheral blood from patients with asthma
|Journal of Allergy and Clinical Immunology|2014|379